Skip to main content
SpringerLink
Log in

No increased risk of UTIs with SGLT-2 inhibitor use

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dave CV, et al. Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study. Annals of Internal Medicine : 30 Jul 2019. Available from: URL: http://dx.dopi.org/10.7326/M18-3136

  2. Filion KB, et al. Sodium-Glucose Cotransporter-2 Inhibitors and Severe Urinary Tract Infections: Reassuring Real-World Evidence. Annals of Internal Medicine : 30 Jul 2019. Available from: URL: http://dx.doi.org/10.7326/M19-1950

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

No increased risk of UTIs with SGLT-2 inhibitor use. Reactions Weekly 1765, 10 (2019). https://doi.org/10.1007/s40278-019-65767-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-65767-7

Search

Navigation